 |
 |
|
|
|
Irinotecan Hydrochloride,GMP and USDMF |
 |
100286-90-6 |
 |
100286-90-6 |
 |
Irinotecan is an antineoplastic enzyme inhibitor primarily used in the treatment of colorectal cancer. |
 |
Assay:NLT98% |
Industrial field |
pharmaceutical |
|
|
 |
|
|
|
 |
There are no existing companies to distribute selected chemical product |
|
 |
|
|
|